European Medicines Agency review of midostaurin (Rydapt) for the treatment of adult patients with acute myeloid leukaemia and systemic mastocytosis

بواسطة Tzogani, Kyriaki, Yu, Yang, Meulendijks, Didier, Herberts, Carla, Hennik, Paula, Verheijen, Remy, Wangen, Torunn, Dahlseng Håkonsen, Gro, Kaasboll, Torny, Dalhus, Marianne, Bolstad, Bjorg, Salmonson, Tomas, Gisselbrecht, Christian, Pignatti, Francesco
الحاوية / القاعدة ESMO Open (2019)

The European Medicines Agency Approval of Axitinib (Inlyta) for the Treatment of Advanced Renal Cell Carcinoma After Failure of Prior Treatment With Sunitinib or a Cytokine: Summar...

بواسطة Tzogani, Kyriaki, Skibeli, Venke, Westgaard, Ingunn, Dalhus, Marianne, Thoresen, Hege, Slot, Karsten Bruins, Damkier, Per, Hofland, Kenneth, Borregaard, Jeanett, Ersbøll, Jens, Salmonson, Tomas, Pieters, Ronny, Sylvester, Richard, Mickisch, Gerald, Bergh, Jonas, Pignatti, Francesco
الحاوية / القاعدة Oncologist (2015)

The European Medicines Agency Review of Gilteritinib (Xospata) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an FLT3 Mutation

بواسطة Tzogani, Kyriaki, Røshol, Hilde, Olsen, Helga Haugom, Aas, Ida B., Dalhus, Marianne Løiten, Håkonsen, Gro Dahlseng, Nilssen, Laila Sortvik, Lindberg, Vibeke, Økvist, Mats, Bolstad, Bjørg, Rogovska, Irēna, Karpova, Natalja, Enzmann, Harald, Gisselbrecht, Christian, Pignatti, Francesco
الحاوية / القاعدة Oncologist (2020)